End-to-End Phase I-IV Clinical Development

ICH‑GCP & ISO 14155

21 CFR Part 11

500+ global sites

FDA/MHRA‑ready

Our Impact

500+

Global Sites

9+

Therapeutic Areas

Phase IIV

Clinical Development

Therapeutic Areas

Ophthalmology, Respiratory, Neurology, Endocrinology, Oncology, Dermatology, Infectious Diseases, Pain, Rare Disease

End-to-end Services

Protocol design, site selection, project management, monitoring, data management, biostatistics, medical writing

Recent Studies

Phase I FIH, Phase II PoC, Phase III pivotal, Phase IV observational

Quality & Compliance

ICH-GCP, 21 CFR Part 11, GDPR, ISO 14155

Clinical Development

clinical trial patient doctor

We deliver full-service clinical trial support across Phases I-IV: feasibility & start-up, site activation, monitoring, data management, biostatistics, medical writing and regulatory submissions. Our experienced teams and global site network help sponsors accelerate development while ensuring patient safety and data integrity.

Core Capabilities

Project Management & Monitoring: riskbased oversight, KPI tracking, vendor coordination

Data Management & Biostatistics: EDC build and validation, data cleaning, statistical analysis and reporting

Regulatory Submissions

Safety & Pharmacovigilance: case processing, medical review, aggregate reports

Case Studies & Expertise

Oncology Operations

Feasibility, start-up, monitoring and enrollment delivery.

Biometrics Excellence

EDC build, data management, programming and analysis outputs.

Regulatory & QA

Inspection readiness, submissions and GCP quality systems.

Our mission

Our mission is to advance healthcare by delivering high-quality, efficient clinical trials that bring safe and effective therapies to patients faster. We combine scientific rigor, operational excellence, and patient-centered design to exceed sponsor and regulatory expectations.

Capabilities

Clinical operations, safety, biometrics, medical writing, and regulatory strategy to support your program end‑to‑end.

Therapeutic Areas

Oncology

Solid tumors, hematology, immuno-oncology, biomarker-driven designs

Neurology

Epilepsy, movement disorders, neurodegeneration, rare CNS disorders

Respiratory

Asthma, COPD, interstitial lung disease, pulmonary infections

Ophthalmology

Retina, glaucoma, anterior segment, inflammatory eye disease

Endocrinology

Diabetes, obesity, thyroid and metabolic disorders

Dermatology

Psoriasis, atopic dermatitis, acne, autoimmune skin disease

Infectious Diseases

Antivirals, antibacterials, vaccines, emerging pathogens

Pain

Acute and chronic pain, neuropathic and musculoskeletal conditions

Rare Disease

Genetic and orphan indications, natural history and interventional trials